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Purpose:  To  evaluate  the  usefulness  of diffusion-weighted  imaging  (DWI)  with  a multiple  b value  SE-
EPI  sequence  on  a 3.0 T MR  scanner  for  staging  of pelvic  lymph  nodes  in  patients  with  prostate  cancer
candidate  to radical  prostatectomy  and  extended  pelvic  lymph  node  dissection  (PLND).
Materials  and  methods:  Institutional  review  board  approval  was  obtained  and  written  informed  consent
was taken  from  all enrolled  subjects.  A  series  of 26  patients  with  pathologically  proven  prostate  cancer
(high  or  intermediate  risk  according  to D’Amico  risk groups)  scheduled  for radical  prostatectomy  and
PLND  underwent  3 T MRI  before  surgery.  DWI  was  performed  using  an  axial  respiratory-triggered  spin-
echo echo-planar  sequence  with  multiple  b values  (500,  800,  1000,  1500  s/mm2)  in all  diffusion  directions.
ADC  values  were  calculated  by  means  of  dedicated  software  ﬁtting  the  curve  obtained  from  the  corre-
sponding  ADC  for each  b value.  Fitted  ADC  measurements  were  performed  at the level  of  proximal  and
distal  external  iliac,  internal  iliac,  and  obturator  nodal  stations  bilaterally.  Lymph  node  appearance  was
also assessed  in  terms  of short  axis, long-to-short  axis  ratio,  node  contour  and  intranodal  heterogeneity
of  signal  intensity.
Results: A  total  of 173  lymph  nodes  and  104  nodal  stations  were  evaluated  on DWI  and pathologi-
cally analysed.  Mean  ﬁtted  ADC  values  were  0.79  ±  0.14  × 10−3 mm2/s  for metastatic  lymph  nodes  and
1.13  ±  0.29  × 10−3 mm2/s  in  non-metastatic  ones  (P <  0.0001).  The  cut-off  for ﬁtted  ADC obtained  by
ROC curve  analysis  was  0.91  × 10–3 mm2/s. A  two-point-level  score  was  assigned  for each qualitative
parameter,  and the  mean  grading  score  was  6.09  ± 0.61  for  metastastic  lymph  nodes  and  5.42 ±  0.79 for
non-metastatic  ones,  respectively  (P = 0.001).  Using  a  score  threshold  of  4  for  morphological,  structural,
–3 2and  dimensional  MRI analysis  and  a cut--off  value  of  0.91  ×  10 mm /s for  ﬁtted  ADC  measurements
of pelvic  lymph  nodes,  per--station  sensitivity,  speciﬁcity,  PPV,  NPV  and  diagnostic  accuracy  were  100%,
7.9%,  15.6%,  100%  and  21.3%,  and  84.6%,  89.5%,  57.9%,  97.1%  and  88.8%,  respectively.
Conclusions:  3.0T  DWI  with  a multiple  b value  SE-EPI  sequence  may  help  distinguish  benign  from  malig-
nant  pelvic  lymph  nodes  in patients  with  prostate  cancer.
©  2015  The  Authors.  Published  by Elsevier  Ltd.  This  is an  open  access  article  under  the  CC  BY-NC-ND. Introduction
The presence of pelvic lymph node metastases in patients with
rostate cancer is of major relevance since it is crucial for treat-
ent planning. Currently, pelvic lymph node dissection (PLND)
epresents the most accurate and reliable staging procedure for
he detection of lymph node invasion in prostate cancer, but not all
∗ Corresponding author.
E-mail address: lfaggioni@sirm.org (L. Faggioni).
ttp://dx.doi.org/10.1016/j.ejro.2015.11.004
352-0477/© 2015 The Authors. Published by Elsevier Ltd. This is an open access article 
/).license  (http://creativecommons.org/licenses/by-nc-nd/4.0/).
patients are at the same risk of harboring pelvic lymph node metas-
tases [1]. Radical prostatectomy with PLND is a time-consuming
and relatively expensive procedure that requires inpatient hospi-
talization and is associated with potentially early post-operative
complications (such as bleeding, infections, lymphocele) and late
post-operative complications (e.g., urinary incontinence, erectile
dysfunction, anastomotic stenosis). For this reason, non-invasive
imaging is important to streamline the surgical resection protocol
and has a potential role in selecting patients who  are suitable for
PLND [2,3].
under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.
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Table  1
D’Amico risk groups.
High risk PSA* > 20 or Gleason ≥ 8 or are in clinical stage T2c-3a
Intermediate riskGleason score of 7 or PSA of 10–20 or are in clinical stage T2b
Low risk PSA ≤ 10 ng/ml and Gleason score ≤ 6 or are in clinical stage T1-2a
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Table 2
Demographic and biometric information (patients n = 26).
Patients, N 26
Age, mean (range) 66.3 (49–76)
Preoperative PSA, mean (range) 14.8 (3–40.6)
Biopsy Gleason grade
6 (3 + 3) 2
7  (3 + 4) 7
7  (4 + 3) 6
8  (4 + 4) 5
9 (4 + 5) 4
9 (5 + 4) 2
Dissected lymph nodes, n 442
Lymph node count, mean (range) 17 (7–32)
Dissected nodal stations, n 212
tify each of these parameters, a grading score (Table 3) was assignedSA∗ = prostate-speciﬁc antigen, expressed in ng/ml.
Nodal staging is routinely performed by cross-sectional imaging
uch as computed tomography (CT) and is based on the morpho-
ogical and dimensional features of lymph nodes, including their
ize (with a threshold of 10 mm in short axis diameter or clusters
f smaller regional lymph nodes), long-to-short axis ratio, bor-
ers (lobulated or spiculated), extra-capsular spread, and abnormal
nternal architecture (such as central necrosis) [4,5].
MR diffusion-weighted imaging (DWI) is a non-invasive imag-
ng technique yielding unique information on molecular diffusion
roperties of tissues. DWI  allows to evaluate the random thermal
otion of water molecules (Brownian motion), which is generally
imited in cancer tissues because of their relatively high cell den-
ity and abundance of cellular membranes as compared to normal
issues. The mobility of water molecules is quantiﬁed by the appar-
nt diffusion coefﬁcient (ADC) [4]. Conventionally, restricted water
iffusion in areas of high cellular density (e.g., tumors) results in
ow ADC values compared with areas with lower cellular density,
hich typically show higher ADC values.
As to the differential diagnosis between benign and malignant
ymph nodes with DWI, the high signal intensity of lymph nodes
n high b value images must not be misinterpreted, because also
eactive nodal hyperplasia can result in increased cellularity and
hus high signal intensity on DWI  images [4]. In clinical practice,
WI  of lymph nodes is performed using high b values to increase
he conspicuity of high cellularity lymph nodes [6], and in this
etting at least two or more b values are used for DWI  analysis.
n light of the above assumptions, quantitative evaluation of ADC
aps might provide useful information for presurgical assessment
f pelvic lymph nodes, which however needs to be interpreted with
aution [4].
The purpose of our study was to evaluate the usefulness of DWI
ith a multiple b value spin-echo echo-planar (SE-EPI) sequence on
 3.0 T MR  scanner for staging of pelvic lymph nodes in patients with
rostate cancer candidate to radical prostatectomy and extended
LND.
. Materials and methods
.1. Patients population
Between June 2011 and November 2013, a series of 26 patients
median age 66.3 ± 6.7 years, range 49–76 years) with pathologi-
ally proven prostate cancer (high or intermediate risk according
o D’Amico risk groups; Table 1) scheduled for radical prostatec-
omy and PLND underwent MRI  before surgery. Exclusion criteria
ere the following: known bone metastases, previous treatment
or prostate cancer, previous/concomitant malignancy, and con-
raindications to MRI.
All patients were examined on a 3.0 T MRI  scanner (Discovery
R750; GE Healthcare, Milwaukee, WI)  using a phased array 8-
hannel surface coil (gradient ﬁeld strength 50 mT/m, slew rate
00 T/m/s). Institutional review board approval was obtained, and
 written informed consent was obtained from all enrolled patients
fter the nature of the procedure had been fully explained.All patients underwent radical prostatectomy within 15 days
f MRI. Lymph nodes were surgically mapped and classiﬁed into
en different anatomic regions (proximal and distal external iliac,Metastatic nodal stations, n/N (%) 21/212 (9.9)
Non-metastatic nodal stations, n/N (%) 191/212 (90.1)
proximal and distal internal iliac, and obturator, each on both the
right and left sides).
In 6 out of 26 patients (23%), extended lymphadenectomy
including the ten above-mentioned nodal stations was performed,
while in the remaining 20 patients (77%) all ten nodal stations
were not completely removed at the surgeon’s discretion, since
lymphadenectomy was  not extended to stations where lymph
nodes were neither evident on MRI  nor intraoperatively visible
or palpable. A total of 212 nodal stations, corresponding to 442
lymph nodes (median 17 lymph nodes per patient, range 7–32 per
patient), were surgically removed and pathologically analysed. A
pathologist with more than 15 years of experience in urogenital
pathology was  responsible for assessing all pathological specimens,
and received an anatomical template marking the dissected nodal
stations. However, if no nodes were found, the entire tissue under-
went pathological analysis.
Demographic and biometric data of the study group are sum-
marised in Table 2.
2.2. MR image acquisition protocol and analysis
The entire pelvis spanning from the aortic bifurcation to the
pubic symphysis was imaged by performing, as a ﬁrst step, a fast
spin echo (FSE) T1-weighted sequence (TR 600–800 ms,  TE 6–7 ms;
slice section 4 mm,  spacing 0.4 mm,  matrix 320 × 320, 3 Nex) and
subsequently, a FSE T2-weighted sequence (TR 5000–8000 ms, TE
80–85 ms,  slice section 4 mm;  spacing 0.4 mm,  matrix 384 × 352, 4
Nex) acquired in the transverse and coronal planes.
DWI  was  performed using an axial respiratory-triggered SE-EPI
sequence with multiple b values (500, 800, 1000, 1500 s/mm2) in
all diffusion directions. Imaging parameters were the following: TR
(repetition time automatically adapted to the patient’s breathing
pattern) 3500–9200 ms,  TE 65–69 ms,  slice section 4 mm,  spacing
0.4 mm,  matrix 96 × 224, 4 Nex. The acquisition time for the whole
MRI  examination ranged from 25 to 30 min. The multiple b value
DWI  acquisition lasted no more than 6 min  overall.
MR images were analysed in consensus by two radiologists with
more than 15 years of experience in urogenital imaging and MRI,
who were blinded to patient-related information such as patient
identiﬁcation data, history or ﬁnal diagnosis. Lymph nodes were
identiﬁed on T2-weighted FSE images and classiﬁed into ten differ-
ent stations, as described in Section 2.1.
The features of pelvic lymph nodes on the FSE MR  images were
assessed in terms of their short axis, long-to-short axis ratio, node
contour, and heterogeneity of intranodal signal intensity. To quan-based on a two-point-level system, and the global grading of each
nodal station was obtained by summing the point-level obtained
for each of the following four parameters:
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Table 3
Grading score system.
1 point 2 points
Intranodal signal intensity Homogeneous Inhomogeneous
Short axis ≤10 mm >10 mm
Nodal contour Regular Irregular
Long-to-short axis ratio ≥2 <2
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Table 4
Location of pelvic nodal stations and number of lymph nodes per station analysed.
Pelvic nodal stations No. No. of lymph nodes
Right proximal external iliac 16 34
Left proximal external iliac 7 12
Right distal external iliac 16 29
Left distal external iliac 13 26
Right proximal internal iliac 8 10
Left proximal internal iliac 1 1
Right distal internal iliac 4 4
Left distal internal iliac 5 7
Right obturator 14 17
Left obturator 19 32
Right common iliac 1 1
(Fig. 4). The ADC threshold value yielding the best separation
between metastatic and non-metastatic lymph nodes as deter-
mined by ROC curve analysis was 0.91 × 10−3 mm2/s. Accordingly,
Table 5
Mean total grading score and mean ﬁtted ADC values in the two  different groups of
pelvic lymph nodes.
Pathologically metastatic Pathologically benign P value
No. of nodal stations 19 85
ADC value* 0.79 ± 0.14 1.13 ± 0.29 <0.0001
(Mean ± SD, range) 0.63–1.12 0.10–2.20
Global grading score 6.09 ± 0.61 5.42 ± 0.79 0.001. Short axis ≤ 10 mm (1 point) or > 10 mm (2 points)
. Long-to-short axis ratio ≥ 2 (1 point) or < 2 (2 points)
. Regular (1 point) or irregular node contour (2 points)
. Homogeneous (1 point) or inhomogeneous intranodal signal
intensity (2 points).
Consequently, the global Grading Score ranged between 4 (indi-
ator of a benign nature) and 8, i.e., the worst score indicator of a
alignant nature.
The ADC values of pelvic lymph nodes were calculated on a
edicated workstation (Advantage Windows 4.5, GE Healthcare,
ilwaukee, WI). All ADC measurements were obtained from the
ultiple b value SE-EPI DWI  sequence by means of dedicated soft-
are ﬁtting the curve obtained from the corresponding ADC for
ach b value. To calculate ﬁtted ADC values, regions of interest
ROIs) were placed in lymph nodes by another radiologist with
 years of experience in abdominal imaging and MRI, who was
linded to patient information including clinical history, previous
adiological ﬁndings, and ﬁnal diagnosis. To measure ﬁtted ADC val-
es, care was taken to place three ROIs as similar as possible inside
ach lymph node. In order to maximize the reproducibility of mea-
urements, circular ROIs were chosen to sample the largest possible
rea within pelvic lymph nodes. To avoid errors due to partial vol-
me  averaging, ROIs not smaller than 30 mm2 were traced, and
odes smaller than 5 mm in their largest diameter were excluded
rom quantitative analysis.
For each ﬁtted ADC value, we obtained three ADC measurements
nd considered their average value. Likewise, in nodal stations com-
rising multiple lymph nodes we measured the ﬁtted ADC value of
very lymph node and considered their average value.
.3. Statistical analysis
Statistical analysis was carried out using commercially available
tatistical software (MedCalc version 12.6.1.0, www.medcalc.org).
The distribution of qualitative variables was expressed as the
elative frequency of the various modalities under observation,
hile the distribution of quantitative variables was expressed as
ean, standard deviation, minimum, maximum, and number of
bservations.
The two-tailed Student’s t test was used to compare the ﬁtted
DC values measured at nodal stations in the metastatic and non-
etastatic lymph node groups. The global Grading Scores in the
wo groups were compared using the two-tailed Mann–Whitney
est. A P value less than 0.05 was set as threshold for statistical
igniﬁcance.
To evaluate the diagnostic performance of the ﬁtted ADC in dif-
erentiating metastatic from non-metastatic lymph nodes, receiver
perating characteristic (ROC) curve analysis was performed to
xtract the optimal threshold yielding the best separation between
hem. Sensitivity, speciﬁcity, positive predictive value (PPV), nega-
ive predictive value (NPV) and diagnostic accuracy were calculated
oth for the ﬁtted ADC values and the global grading score.Left common iliac 0 0
Total 104 173
3. Results
All patients tolerated the MR  examination well and were able
to complete the MR  protocol.
Imaging analysis was  limited to 104 nodal stations for a total
of 173 lymph nodes, since only nodes with a maximum diameter
not smaller than 5 mm and available pathological diagnosis were
included. All remaining lymph nodes in the various pelvic nodal
stations were not considered and therefore excluded from analy-
sis. Location of the pelvic nodal stations and the number of lymph
nodes per station analysed are reported in Table 4.
The mean global grading score was  6.09 ± 0.61 (range 5–7)
in the metastatic node group and 5.42 ± 0.79 (range 4–7) in the
non-metastatic node group (P = 0.001). A Grading Score equal to 4
(highly indicative of a benign nature) was found in 6/85 nodal sta-
tions only of the non-metastatic node group, while the remaining
79 nodal stations showed a grading score greater than 4 (a total
grading score > 4 was considered suspicious for malignancy). In the
metastatic node group, all nodal stations showed a grading score
greater or equal than 5. All lymph nodes in the metastatic node
group detected on FSE images were smaller than 10 mm in their
short axis, and one patient had a benign lymph node larger than
10 mm (13.5 mm)  in its short axis.
With a score threshold of 4, per-station sensitivity, speciﬁcity,
PPV, NPV and diagnostic accuracy for FSE-MRI analysis were 100%,
7.9%, 15.6%, 100% and 21.3%, respectively.
The mean ﬁtted ADC value was  0.79 ± 0.14 × 10−3 mm2/s in the
metastatic node group and 1.13 ± 0.29 × 10−3 mm2/s in the non-
metastatic node group (P < 0.0001).
Mean total Grading Scores and mean ﬁtted ADC values in the
two different lymph node groups are reported in Table 5. Exam-
ples of ﬁndings related to benign and malignant lymph nodes are
illustrated in Figs. 1–3 .
The area under the ROC curve related to the ADC difference
between the metastatic and non-metastatic node groups was 0.89(Mean ± SD, range) 5–7 4–7
* Values expressed as 10−3 mm2/s. SD = standard deviation.
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Fig. 1. An example of benign lymph node. (a) T2w image. (b) DW image. (c) ADC map. (d) Grading score = 6.
Fig. 2. An example of metastatic lymph node. (a) T2w image. (b) DW image. (c) ADC map. (d) Grading score = 7.
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Fig. 3. Another example of metastatic lymph node. (a) T2w image. (b) DW image. (c) ADC map. (d) Grading score = 7.
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Table 6
MRI  ﬁndings according to the apparent diffusion coefﬁcient (ADC) map per nodal
station (n = 104).
ADC value Positive pathological specimen
−3 2ig. 4. The receiver operating curve (ROC) analysis showed an area under the curve
AUC) of 0.89.
 ﬁtted ADC value equal to or less than 0.91 × 10−3 mm2/s was
onsidered to be associated with lymph node metastasis (Table 6).
Finally, per-station sensitivity, speciﬁcity, PPV, NPV values and
iagnostic accuracy for DWI  analysis were 84.6%, 89.5%, 57.9%,
7.1% and 88.8%, respectively.
. Discussion
Preoperative detection of lymph node metastases in patients
ith prostate cancer is crucial for selection of the appropriatereatment strategy and is therefore relevant for patient progno-
is. Some authors favor performing PLND in all patients who are
andidates for radical prostatectomy, regardless of baseline tumor
haracteristics [7]. Nevertheless, the staging beneﬁt is balanced by≤0.91 × 10 mm /s 15
>0.91 × 10−3 mm2/s 4
the risk of exposing a certain number of patients to signiﬁcant and
potentially unnecessary PLND-related complications. Conventional
cross-sectional imaging techniques such as CT cannot accurately
differentiate between benign and malignant lymph nodes, espe-
cially in the case of smaller nodes (<10 mm), so that smaller
metastases often go undetected. Similarly, standard MRI, dynamic
contrast-enhanced MRI, and even MR spectroscopic imaging have
shown no advantage over CT in predicting metastatic involve-
ment of lymph nodes [8,9]. Indeed, recent studies have shown that
meticulous lymph node dissection in patients with prostate can-
cer discloses a rate of metastases as high as 25% in patients with
preoperatively negative standard imaging studies [10]. The use of
lymphotropic ultrasmall superparamagnetic particles of iron oxide
(USPIO) as MRI  contrast agents has been evaluated as well. In a
study including 80 men  with clinically localized prostate cancer,
this technique has shown to increase the sensitivity for detection of
lymph node metastases from 35% when using MRI  alone to 90% [11].
However, image interpretation is time-consuming, since a node-
by-node comparison must be made between pre- and post-contrast
MRI  images, and requires special expertise. Moreover, this tech-
nique cannot overcome the problem of false-negative normal-sized
lymph nodes harboring micrometastases, and USPIO agents are not
available in the daily clinical practice [11]. However, the combina-
tion of DWI  and USPIO has yielded interesting results [12]. In fact,
in normal lymph nodes, the uptake of iron oxide particles by the
reticuloendothelial system produces a signal decrease on T2/T2*-
weighted images, while malignant lymph nodes show high signal
intensity due to the combination of the two effects (i.e., reduced dif-
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[
[
[
bladder cancer including pelvic lymph node staging: a critical analysis of the
literature, Eur. Urol. 61 (2012) 326–340.
[16] S.J. Vinnicombe, A.R. Norman, V. Nicolson, J.E. Husband, Normal pelvic lymph
nodes: evaluation with CT after bipedal lymphangiography, Radiology 194
(1995) 349–355.V. Vallini et al. / European Journ
usion together with relatively unchanged T2/T2* following USPIO
dministration), resulting in better separation from normal lymph
odes, which are supposed to become invisible due to the reduced
2/T2*.
Lymph node assessment with DWI  is currently one of the most
nteresting ﬁelds of research in oncological imaging, and ADC is
 quantitative parameter that reﬂects the diffusion of water and
issue perfusion. In particular, DWI  has been investigated as a
otential tool to differentiate benign from malignant lymph nodes
n head and neck cancer [13]. A large spectrum of ADC values among
etastatic lymph nodes was found and can be explained by differ-
nces in the cellular composition of tumors. When comparing ADC
alues for any organ and lesion reported in the literature, attention
as also to be paid to the choice of the underlying b value, on which
DC is strongly dependent [14].
Based on our preliminary ﬁndings, DWI  may  help distinguish
enign from malignant lymph nodes in patients with prostate
ancer, since ﬁtted ADC value of metastatic lymph nodes were sig-
iﬁcantly lower than those of non-metastatic lymph nodes with a
PV as high as 97.1%.
As to the morphological, structural, and dimensional MRI  analy-
is of pelvic lymph nodes, we found a signiﬁcant difference between
he total Grading Score in the metastatic and non-metastatic node
roups, yet very low speciﬁcity, PPV and diagnostic accuracy were
bserved. We  also found that the mean diameter (short axis) of
etastatic lymph nodes was smaller than 10 mm (5.77 ± 1.81 mm,
ange 3.7–9 mm),  which is the standard cut-off reported in the lit-
rature for pelvic lymph nodes [15,16].
To the best of our knowledge, no other study has so far speciﬁ-
ally tackled the issue of nodal staging in prostate cancer by means
f DWI  using ﬁtted ADC measurements obtained from a multi-
le b value DWI  sequence. This kind of evaluation overcomes the
roblem of choosing a speciﬁc b value for ADC measurements,
ecause ﬁtted ADC are calculated on the basis of a logarithmic curve
btained with multiple b values. Moreover, the usage of a higher
agnetic ﬁeld strength (3.0 T versus 1.5 T) should be advantageous
s it can provide higher spatial resolution and signal-to-noise ratio.
However, to maximize accuracy in MRI-based lymph node stag-
ng, it is important to be aware of the following potential pitfalls of
WI:
. Small nodes (<4 mm in long axis diameter) may  be displayed
and anatomically localised using DWI, but the presence of malig-
nant disease cannot always be established based on the sole DWI
ﬁndings;
. ADC measurements in normal-sized lymph nodes may  be
degraded by partial volume effects;
. Necrosis inside metastatic nodes may  lead to false-negative
results due to the resultant ADC increase, and therefore macro-
scopic areas of intranodal necrosis must be carefully discarded;
. Any reactive changes in lymph nodes may  result in lower ADC
values;
. Technical factors such as image noise and motion artefacts can
lead to systematic or random errors in ADC quantiﬁcation;
. Micrometastases in smaller lymph nodes with insufﬁcient intra-
nodal tumor burden may  not impede water diffusion and can
therefore lead to false-negative results [4].
Besides, our study has several limitations. First, the number of
atients (and in particular, of those with malignant lymph nodes)
as relatively low. Second, we excluded from image analysis allymph nodes smaller than 5 mm in their maximum diameter,
hich still could be malignant in nature. Third, a station-by-station
nstead of a node-by-node analysis was performed. Nevertheless,
urgical specimens often included multiple lymph nodes, so it wasadiology Open 3 (2016) 16–21 21
not possible to have a 100% pathological correlation at each single
lymph node level, especially in the case of multiple lymph nodes at
a single nodal station.
In conclusion, our preliminary experience suggests that 3.0 T SE-
EPI diffusion-weighted MR imaging with multiple b values may
help distinguish benign from malignant pelvic lymph nodes in
patients with prostate cancer. In particular, ﬁtted ADC measure-
ments could represent a useful method in this differential diagnosis
when using a threshold value of 0.91 × 10–3 mm2/s. Since DWI
requires only a very short prolongation of the standard MRI  exam-
ination protocol, this technique could be recommended as part of
a routine MRI  study of the pelvis as an additional tool for charac-
terisation of pelvic lymph nodes. However, further studies with a
larger patient sample are necessary to conﬁrm our ﬁndings.
Conﬂict of interest
None.
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